TROY, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCID: ZIVO) ("ZIVO" or the "Company") announced today that it is transitioning its common stock to quotation on the OTCID marketplace. Zivo Bioscience began trading on OTCID as of Monday, May 11, 2026. Transitioning to OTCID is a common step for companies seeking to maintain public trading while aligning with a marketplace that offers stream...
TROY, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), today issued the following letter to shareholders from Chairman, President and Chief Executive Officer John B. Payne. Dear Fellow Shareholders, I am writing to inform you of a significant and carefully considered decision by the Board of Directors of ZIVO Bioscience, Inc. (“ZIVO” or the “Company”): we intend to deregister the Co...
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.